Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR

Aniara Diagnostica LLC

West Chester, OH, US

ANIARA DIAGNOSTICA, LLC appears in FDA device records in West Chester, OH. FDA records list one 510(k) clearance, no PMA records and one registered establishment. As of , FDA records show 11 recalls for this company, and at least one establishment registration is current.

FDA records held for this company

510(k) clearances
1
PMA records
0
Recall records
11
Registered establishments
1

510(k) clearance history

FDA records hold 1 510(k) clearance for Aniara Diagnostica LLC in 2009.

Clearances by year, as a table
510(k) clearance decisions for Aniara Diagnostica LLC, by decision year
YearClearances
20091
510(k) clearances on record, most recent first
K numberDeviceProduct codeDecisionDecision date
K083729HEMOCLOT QUANTI- V-L, FACTOR V-L CALIBRATOR, BIOPHEN V-L CAL (UNDILUTED), BIOPHEN ACT. PC-R CONTROL PLASMA AND BIOPHENGGWSubstantially Equivalent

Registered establishments

FDA registered establishments for Aniara Diagnostica LLC, with the product codes listed at each
RegistrationFEIEstablishmentAddressRegistration expiresProduct codes listed
30050176643005017664ANIARA DIAGNOSTICA, LLC7768 Service Center Dr, West Chester, OH 45069 US2026No device listings on this registration

Registration numbers link to the FDA registration and listing record for that establishment.

FDA product codes

Recall records

Device recall records naming this company, most recent first
RecallProductReasonClassificationInitiatedStatus
Z-2896-20265-PLASMA Bivalirudin Control, Model Number 5D-44905Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.Class IIOpen, Classified
Z-2895-20265-PLASMA Bivalirudin Calibrator, Model Number 5D-46905Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.Class IIOpen, Classified
Z-2894-20265-PLASMA Bivalirudin AMR Verification Kit, Model Number 5D-45905Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.Class IIOpen, Classified
Z-2171-2026ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040AKits from lot FD1265 had been packaged on 17 October 2024 and put on the market with an outdated flyer (8 October 2024), containing incorrect values for the positive control.Class IIOpen, Classified
Z-1227-2023BIOPHEN Protein C 5 kit is for in vitro quantitative determination of Protein C activity on human citrated plasma. Protein C is a glycoprotein, vitamin K dependent, which inhibits coagulation. Protein C in plasma is measured following a specific activation with Protac (Agkistrodom Contortrix), an enzyme extracted from snake venom. Activated protein C hydrolysis the chromogenic substrate (SaPC-21) which release para-nitroaniline (pNA). The amount of pNA released (measured by absorbance at 405 nm) is directly proportional to the concentration of Protein C in the specimen.New warnings and precautionary statements on product labelling: Reagent 2 (R2) of BIOPHEN Protein C 5 contains the chemical substance - Cesium Chloride which changed classification and has become hazardous according to the CLP regulation ((EC) No 1272/2008) is suspected of damaging fertilityClass IIOpen, Classified
Z-1743-2022BIOPHEN UFH Control PlasmaIncorrect product labeling was included in the package.Class IIITerminated
Z-2347-2019ZYMUTEST HIA MonoStrip, IgGAM ELISA kit, Model No. RK041D, for in vitro diagnostic use.Residual crystallization of the microplate and recurrent negative controls out of range.Class IITerminated
Z-2346-2019ZYMUTEST HIA MonoStrip, IgG ELISA kit, Model No. RK041A, for in vitro diagnostic use.Residual crystallization of the microplate and recurrent negative controls out of range.Class IITerminated
Z-1190-2019BIOPHEN LMWH Control C4, REF 224201The manufacturer packaged incorrect versions of the Instructions for Use into specific lots for three device product codes.Class IIITerminated
Z-1189-2019BIOPHEN UFH Control C1, REF 224101The manufacturer packaged incorrect versions of the Instructions for Use into specific lots for three device product codes.Class IIITerminated
Z-1188-2019BIOPHEN UFH Control C2, REF 223901The manufacturer packaged incorrect versions of the Instructions for Use into specific lots for three device product codes.Class IIITerminated

Verification record

There is no verification record for this company. Most companies on this site have none: a record exists only where a company asked to be verified and MDM ran the checks, so the absence of one says nothing about the company.

Where there is a record, this is where it appears: what was checked, when it was checked, and the current status. An MDM Verified badge on another website links to a verify address on this domain that resolves to this section. A badge that does not resolve here is not ours.

What MDM checks, and what it does not

MDM coverage

MDM coverage of this company lists here, newest first. Submit news.

Is this your company?

This page is built from public FDA records. Company pages are free and factual, and stay free whether or not anyone claims them. Membership never changes editorial coverage or vetting outcomes.

Claiming lets Aniara Diagnostica LLC edit what it says about itself and list the categories it works in. It grants no badge: claiming is not verification.

Claim this page

Data as of , FDA export datePage updated Source: openFDA, public domain